That commenter responded that the attestation statement and attestor name should reside within the MRF
The first reason is the cost and accessibility
Keywords: Icotrokinra, Immune-mediated inflammatory disease, Interleukin-23, Oral peptide delivery, Oral systemic peptide, Peptide therapeutics Key Summary Points Introduction Immune-mediated inflammatory diseases (IMIDs), such as psoriasis, psoriatic arthritis, and inflammatory bowel disease (IBD), which includes Crohns disease and ulcerative colitis, encompass a heterogenous group of conditions associated with chronic inflammation [1]
Overview of the rationale for L-glutamine treatment in moderate-severe COVID-19 infection
J Bone Miner Res 30(12):21682178 Gagnon C, Schafer AL (2018) Bone Health After Bariatric Surgery